Showing results (21-30 of 528) with videos related to
Sort By:
Pageof 53
Journal of Neuro-Oncology|September 27, 2023
Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapyArchis R Bhandarkar, Shaan Bhandarkar, Dusica Babovic-Vuksanovic, et al.Plos One|March 2, 2013
The NF-κB RelB protein is an oncogenic driver of mesenchymal gliomaDong Whan Lee, Dhivya Ramakrishnan, John Valenta, et al.Frontiers in Immunology|September 30, 2024
Immune checkpoint pathways in glioblastoma: a diverse and evolving landscapeJulio F Inocencio, Stefan Mitrasinovic, Mohammad Asad, et al.Anesthesia and Analgesia|April 23, 2015
Dexmedetomidine and Mannitol for Awake Craniotomy in a Pregnant PatientKathryn S Handlogten, Emily E Sharpe, Brian C Brost, et al.Neurosurgery|April 13, 2002
Human brain tumor cell culture characterization after immunostimulatory gene transferIan F Parney, Maxine A Farr-Jones, Anu Koshal, et al.World Neurosurgery|December 18, 2022
Effect of Extent of Resection on Survival of Patients with Glioblastoma, IDH-Wild-Type, WHO Grade 4 (WHO 2021): Systematic Review and Meta-AnalysisIgnacio Jusue-Torres, Jonathan Lee, Anand V Germanwala, et al.Plos One|July 31, 2019
Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cellsLiang Zhang, Timothy E Peterson, Victor M Lu, et al.Journal of Neuro-Oncology|August 12, 2009
Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experienceShelly Lwu, Mark G Hamilton, Peter A Forsyth, et al.Neurosurgery|February 7, 2023
Advancements and Technical Considerations for Extracellular Vesicle Isolation and Biomarker Identification in GlioblastomaLuz M Cumba Garcia, Samantha M Bouchal, Megan M J Bauman, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 28, 2002
Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12Ian F Parney, Maxine A Farr-Jones, Kevin Kane, et al.Pageof 53